Sands Capital Management
REGN icon

Sands Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-856,472
Closed -$479M 84
2020
Q3
$479M Buy
856,472
+17,057
+2% +$9.55M 1.04% 34
2020
Q2
$524M Buy
839,415
+695
+0.1% +$433K 1.27% 28
2020
Q1
$410M Sell
838,720
-13,991
-2% -$6.83M 1.37% 26
2019
Q4
$320M Sell
852,711
-36,777
-4% -$13.8M 0.93% 31
2019
Q3
$247M Sell
889,488
-81,678
-8% -$22.7M 0.79% 36
2019
Q2
$304M Sell
971,166
-1,016,547
-51% -$318M 0.9% 31
2019
Q1
$816M Sell
1,987,713
-93,116
-4% -$38.2M 2.52% 14
2018
Q4
$777M Sell
2,080,829
-96,564
-4% -$36.1M 2.77% 13
2018
Q3
$880M Sell
2,177,393
-128,418
-6% -$51.9M 2.49% 16
2018
Q2
$795M Sell
2,305,811
-98,276
-4% -$33.9M 2.28% 16
2018
Q1
$828M Sell
2,404,087
-152,525
-6% -$52.5M 2.45% 15
2017
Q4
$961M Sell
2,556,612
-83,298
-3% -$31.3M 2.91% 13
2017
Q3
$1.18B Sell
2,639,910
-154,049
-6% -$68.9M 3.54% 10
2017
Q2
$1.37B Sell
2,793,959
-139,485
-5% -$68.5M 4.13% 6
2017
Q1
$1.14B Buy
2,933,444
+630,642
+27% +$244M 3.57% 10
2016
Q4
$845M Sell
2,302,802
-194,576
-8% -$71.4M 2.95% 11
2016
Q3
$1B Sell
2,497,378
-162,363
-6% -$65.3M 2.96% 13
2016
Q2
$929M Sell
2,659,741
-728,180
-21% -$254M 2.87% 13
2016
Q1
$1.22B Sell
3,387,921
-310,632
-8% -$112M 3.61% 9
2015
Q4
$2.01B Sell
3,698,553
-439,631
-11% -$239M 5.17% 3
2015
Q3
$1.92B Sell
4,138,184
-80,784
-2% -$37.6M 5.37% 4
2015
Q2
$2.15B Sell
4,218,968
-791,193
-16% -$404M 5.29% 3
2015
Q1
$2.26B Buy
5,010,161
+23,984
+0.5% +$10.8M 5.38% 3
2014
Q4
$2.05B Buy
4,986,177
+18,711
+0.4% +$7.68M 4.87% 5
2014
Q3
$1.79B Buy
4,967,466
+60,104
+1% +$21.7M 4.45% 6
2014
Q2
$1.39B Buy
4,907,362
+895,300
+22% +$253M 3.49% 12
2014
Q1
$1.2B Buy
4,012,062
+279,382
+7% +$83.9M 3.14% 14
2013
Q4
$1.03B Sell
3,732,680
-44,677
-1% -$12.3M 2.69% 17
2013
Q3
$1.18B Buy
3,777,357
+638,564
+20% +$200M 3.3% 12
2013
Q2
$706M Buy
+3,138,793
New +$706M 2.38% 22